Related by context. All words. (Click for frequent words.) 87 Screening Trial DMIST 81 Screening Trial 76 Prostate Lung Colorectal 75 DMIST 72 ACRIN 72 Ovarian PLCO Cancer 71 Evaluation WISE 71 Prostate Cancer Prevention 70 Cholesterol Levels SPARCL 70 VADT 70 Trial NLST 69 PLCO 69 Carotid Revascularization Endarterectomy vs. 69 Aggressive Reduction 68 ExTRACT TIMI 68 Intervention Trial GAIT 68 Stenting Trial CREST 67 BARI 2D 67 CALGB 67 Group RTOG 67 Clinical Antipsychotic Trials 67 prospective longitudinal 67 EBUS FNA 67 Multicenter AIDS 67 ACUITY trial 67 undergone radical prostatectomy 67 Radiation Therapy Oncology 66 multicenter randomized controlled 66 Women Ischemia Syndrome 66 prelicensure 66 substudy 66 prospective multicentre 66 ONTARGET 66 ELCAP 66 multicenter randomized clinical 66 Edge STudy 66 Gynecologic Oncology Group 66 number NCT# ClinicalTrials.gov 66 retrospective cohort study 66 HYVET 66 CT Colonography Trial 66 BCIRG 66 Ovarian Cancer Screening 66 Intervention Effectiveness CATIE 65 NSABP B 65 retrospective cohort 65 retrospectively analyzed 65 EURIDIS 65 CARE HF 65 conducted retrospective cohort 65 Intervention Effectiveness 65 Multiethnic Study 65 CLARITY TIMI 65 ENDEAVOR IV 65 RE LY 65 Renal Cell Carcinoma RCC 65 endometriosis ovarian cysts 65 ENESTnd 65 Intervention Trial 65 Carotid Endarterectomy 64 RTOG 64 REALITY Trial 64 CHAMPION PCI 64 prostate cancer CaP 64 Dialysis Outcomes 64 prospective nonrandomized 64 #F FDG PET 64 CT Colonography 64 Celecoxib APC trial 64 upper endoscopy 64 Carotid Stenting 64 CaPSURE 64 advanced adenoma 64 Glucosamine Chondroitin Arthritis 64 CARDIA 64 BOLDER II 64 medically inoperable 64 Gastric Cancer 64 nonmetastatic 64 FDG-PET/CT 64 NCI Cancer 64 EUS FNA 64 longitudinal cohort study 64 chronic prostatitis 64 abnormal cytology 64 Patient Registry 64 Multicenter Automatic Defibrillator Implantation 63 ASCUS 63 Dietary Modification Trial 63 LUMINATE 63 Adenomas 63 Common Toxicity Criteria 63 ToGA 63 relapsed MM 63 Multicenter 63 AVERROES 63 HGPIN 63 Prostate Disease 63 BZA CE 63 STRIDE PD 63 Abdominal ultrasound 63 Angiographic 63 Invasive Breast Cancer 63 MGd 63 phase IIIb 63 multicentre prospective 63 Subgroup analysis 63 Meta analyzes 63 observational cohort study 63 CT colonography CTC 63 prospective observational cohort 63 renal cell carcinomas 63 Radiology Imaging Network 63 Randomized Controlled 63 ACOSOG Z# 63 WHIMS 63 HCV RESPOND 2 63 advanced adenomas 63 bowel capsule endoscopy 63 RE LY ® 63 immunohistochemical 63 SEER database 63 Lewis H. Kuller 63 Prostate Cancer Outcomes 63 Nonalcoholic Fatty Liver Disease 63 Health Initiative Observational 63 prospective multicenter 63 placebo controlled clinical 63 EVEREST II 63 invasive lobular carcinoma 63 Postmenopausal 63 chromium supplementation 63 ENDEAVOR III 63 carotid artery stenting CAS 63 IMPROVE HF 62 bazedoxifene conjugated estrogens 62 CAPRIE 62 Arch Intern Med 62 Acute Myocardial Infarction 62 PROactive study 62 CIN2 + 62 Cervista HPV HR 62 Computed Tomographic 62 REVIVE Diabetes 62 Accelerated Partial Breast Irradiation 62 Meta Analysis 62 atypical hyperplasia 62 randomized multicenter trial 62 Metastatic Prostate Cancer 62 Lung Cancer Screening 62 PRoFESS 62 European Randomized Study 62 LHRH receptor positive 62 prospective observational 62 multicenter prospective 62 Histopathological 62 Automated Breast Ultrasound 62 SCD HeFT 62 Adenoma Prevention 62 Hepatocellular Carcinoma HCC 62 Thrombolysis 62 BRIM3 62 Acute Coronary Syndromes 62 metastatic colorectal 62 virtual colonography 62 BRCA testing 62 Nymox NX 62 Registry NOPR 62 Framingham Offspring 62 NSABP 62 PLCO trial 62 Virtual Histology 62 Cardiovascular Outcomes 62 HCV SPRINT 62 recurrent glioblastoma multiforme 62 Preclinical Study 62 TAXUS ARRIVE 62 HPTN 62 histologically proven 62 Left Ventricular Dysfunction 62 pancreatic lung 62 Atherosclerosis MESA 62 atypical ductal hyperplasia 62 Cancer Incidence Mortality 62 Immunohistochemistry 62 NICE SUGAR 62 Radiology Imaging Network ACRIN 62 randomized controlled trials RCTs 62 Multicentre 62 Pre RELAX AHF 62 mammographic density 62 Gynecological Cancer 62 #:#-# [033] 62 Acute Decompensated Heart Failure 62 REGARDS 62 SWOG 62 colorectal neoplasms 62 transrectal ultrasound guided 62 PREVENT IV 62 Postmenopausal Women 62 adenoma recurrence 62 Histologic 62 subanalysis 62 INTERHEART study 62 pT2 62 leiomyomas 62 prospective multicenter study 62 selenium supplementation 62 PRESEPT 61 FDG PET imaging 61 fosbretabulin 61 Trandolapril 61 Thromboembolism 61 underwent CABG 61 extracolonic findings 61 endometrial hyperplasia 61 Surgical Treatment 61 ASCO GU 61 Lancet Oncology journal 61 AACR San Antonio 61 multicenter placebo controlled 61 J Nutr 61 Catheterization 61 ALLHAT 61 beta carotene supplementation 61 Multi Ethnic Study 61 PERSEUS 61 Zolinza 61 Peripheral Arterial 61 Multicenter Study 61 Wisconsin Sleep Cohort 61 Swedish Mammography Cohort 61 Young Adults CARDIA 61 Prospective Randomized 61 ARBITER 6 61 Diabetes Interventions 61 invasive lobular 61 Uterine Fibroids 61 ACS NSQIP 61 Colon polyps 61 CALGB # [002] 61 ISEL 61 cardiac computed tomography 61 miRview ™ squamous 61 Arch Surg 61 HF ACTION 61 engineered urethras 61 MADIT CRT 61 HORIZONS AMI trial 61 papillary renal cell carcinoma 61 Pooled Analysis 61 histologically confirmed 61 abacavir Ziagen 61 Outpatient Setting 61 immunohistochemical analysis 61 Early Lung Cancer 61 Pharmacogenetic 61 Endometrial 61 Netherlands Cohort Study 61 #:#-# [035] 61 EchoCRT 61 BRCA1 mutations 61 BR.# 61 CIMZIA TM certolizumab pegol 61 phase IIb study 61 Neoadjuvant 61 Neuroepidemiology 61 Genitourinary Cancers Symposium 61 RECORD1 61 RE LY trial 61 CARDIA study 61 WHEL 61 Hepatotoxicity 61 postmenopausal hormone therapy 61 Coronary Artery Calcium 61 chemoprevention trials 61 AIM HIGH 61 Echocardiographic 61 Breast Cancer Detection 61 journal Urology 61 congenital toxoplasmosis 61 Unstable Angina 61 Heterozygous Familial Hypercholesterolemia 61 adjuvant radiotherapy 61 Prospective Randomized Trial 61 Clinical Outcomes Utilizing Revascularization 61 epithelial ovarian 61 olaparib 61 neoplasias 61 NLSY 61 core needle biopsies 61 carotid artery stenting 61 T1DM 61 Cytogenetic 61 PCI ExTRACT TIMI 61 Randomized Controlled Trials 61 Colposcopy 61 squamous cell lung cancer 61 careHPV 61 HER2 expression 61 Pivotal Clinical Trial 61 Prolongs Survival 61 NHANES III 61 Prospective Multicenter 61 AVOREN 61 Framingham Offspring Study 61 Virtual Colonoscopy 61 journal Ophthalmology 61 Cedars Sinai Maxine Dunitz 61 Lp PLA 2 61 Sentinel Lymph Node Biopsy 61 Colorectal Cancers 61 ACCOMPLISH 60 multicenter study 60 ductal carcinomas 60 Pivotal Phase III 60 bone scintigraphy 60 recurrent metastatic 60 Hormone Receptor Positive 60 STEP BD 60 CT Angiography 60 Acute Ischemic Stroke 60 Val HeFT 60 Faslodex 60 Lung Injury 60 MAGE A3 ASCI 60 specific antigen PSA 60 F FDG PET 60 Oral Fingolimod 60 riociguat 60 Spine Patient Outcomes 60 ClinicalTrials.gov 60 NEVO RES 60 Myocardial Infarction 60 Health Initiative WHI 60 undergoing radical prostatectomy 60 cervical cytology 60 subgroup analyzes 60 ovarian endometrial 60 TRITON TIMI 60 Hematological 60 APPRAISE 60 Trial PCPT 60 colorectal cancer CRC 60 Subgroup analyzes 60 Baltimore Longitudinal Study 60 Wactawski Wende 60 duplex ultrasonography 60 Tom Misteli 60 Arch Neurol 60 Venous Thromboembolism 60 ACCORD ADVANCE 60 Renal Artery 60 Alpha Tocopherol Beta Carotene 60 PROLARIS 60 cytologic 60 relapsed ALL 60 adenomatous 60 colorectal adenoma 60 observational cohort 60 SYNTAX 60 Stenting Trial 60 miRview ™ mets 60 Lipid Lowering Treatment 60 genitourinary cancers 60 Hematologic 60 Endovascular Valve Edge 60 NMP# 60 Timothy Rebbeck 60 nonmelanoma skin cancers 60 ECASS 60 malignant polyps 60 iPrEx 60 ovarian pancreatic 60 longitudinal observational study 60 Prostate Cancers 60 Randomized Phase II 60 MADIT 60 electron beam computed tomography 60 Platelet Inhibition 60 See CLINICAL PHARMACOLOGY 60 journal Resuscitation 60 chlamydial infection 60 cytological 60 adenomatous polyps 60 confirmatory clinical 60 sentinel node biopsy 60 retrospective observational study 60 Phase III AFFIRM 60 ongoing Phase IIIb 60 HER2 positive cancers 60 Prognostic Value 60 precancerous tumors 60 Dr. Kandzari 60 TIMI Study Group 60 skin sterol 60 PERSEUS clinical program 60 NMIBC 60 #:#-# [007] 60 Raloxifene Evaluation MORE 60 cerebral microbleeds 60 International Verapamil SR 60 SPIRIT FIRST 60 #:#-# [024] 60 phase IIb clinical 60 NCT# ClinicalTrials.gov 60 Squamous 60 ZACTIMA 60 J Am Coll 60 CAMMS# 60 oesophageal adenocarcinoma 60 Breast Specific Gamma 60 Inflammatory Bowel Diseases 60 NSTE ACS 60 Observational Study 60 Cytopathology 60 immunochemical fecal occult 60 computed tomographic 60 mesotheliomas 60 intraductal 60 Chronic Heart Failure 60 Insulin Resistance Atherosclerosis 60 GOUT 60 DNAwithPap TM Test 60 ANN INTERN MED 60 clinico pathological 60 randomized Phase IIb 60 Imaging BSGI 60 multicenter trials 60 Slone Epidemiology Center 60 Atherosclerosis Risk 60 Deforolimus 60 ORACLE MS 60 CC genotype 60 nonpregnant women 60 Replication NCS R 60 Nephrology Dialysis Transplantation 60 HIV HCV coinfected 60 pediatric malignancies 60 Septin9 60 situ LCIS 60 Cervista HPV 60 Acute Stroke 60 registrational Phase 60 symptomatic fibroids 60 intracranial stenosis 60 Randomised Study 60 recurrent malignant glioma 60 #F FDG PET CT 60 BSGI MBI 60 ASPS statistics 60 AA Amyloidosis 60 scintigraphic 60 Stereotactic Body Radiation Therapy 59 Malignant Melanoma 59 GISSI 59 colon tumors 59 cutaneous melanoma 59 NCCTG N# 59 ILLUSTRATE 59 Neoplasia 59 AIR2 Trial 59 advanced neoplasia 59 journal Arteriosclerosis Thrombosis 59 Phase IIIb study 59 LungAlert TM 59 multicenter phase 59 trials RCTs 59 PLoS ONE journal 59 peritoneal cancer 59 dutasteride 59 flavopiridol 59 urothelial cancer 59 WallFlex Biliary RX 59 REACH Registry 59 Cardiovascular Risk 59 NABTT 59 Prostate Cancer Patients 59 Coronary Artery Bypass Graft 59 recurrent glioma 59 SilverHawk Plaque Excision System 59 evaluating tivozanib 59 Randomized Study 59 positron emission tomography scans 59 Cancer Prevention ATBC 59 thyroid nodules 59 Rheumatology Annual 59 multicentre randomized 59 Overactive Bladder OAB 59 Colorectal 59 COR Analyzer 59 Cancer Genetic Markers 59 Diabetes ACCORD 59 differentiated thyroid 59 National Emphysema Treatment 59 ST Segment Elevation 59 SORT OUT III 59 TG MV 59 KRAS gene mutations 59 galiximab 59 DAPT Study 59 adjuvant radiation 59 prospectively randomized 59 spiral computed tomography 59 HealthGrades analyzed 59 localized prostate 59 Bowel Project NSABP 59 DEXA scan 59 abnormal Pap smear 59 Afatinib 59 Estrogen Receptor 59 Non Alcoholic Steatohepatitis 59 Investigator Initiated 59 colorectal adenomas 59 Bone Metabolism 59 APEX AMI trial 59 underwent resection 59 citalopram Celexa 59 transvaginal sonography 59 grade cervical intraepithelial 59 underwent coronary angiography 59 prostate TURP 59 Cardiac Allograft Rejection 59 prospective randomized controlled 59 screening colonoscopies 59 immunochemical 59 Ischemic Stroke 59 endometrial cancers 59 gefitinib Iressa 59 Epidemiologic studies 59 CYT# potent vascular disrupting 59 DFCI 59 cediranib 59 Genetic Markers 59 HeFT 59 Adjuvant Chemotherapy 59 Oncotype DX TM 59 Cognitive Function 59 Folfox 59 Long Lesion 59 BladderChek 59 Yikyung Park 59 MEND CABG 59 Heart Failure Trial 59 Severe Asthma 59 Histological 59 SCIg 59 nulliparous women 59 evaluating mipomersen 59 MTWA testing 59 crizotinib PF # 59 mg BID dose 59 IDH1 mutation 59 ACTEMRA TM 59 Asthma Intervention 59 TAXUS ATLAS 59 Combination REOLYSIN R 59 #:#-# [031] 59 Uterine Cancer 59 visceral metastases 59 NO# [002] 59 carotid endarterectomy CEA 59 brivanib 59 cytologically confirmed 59 vaginal lesions 59 Fractional Flow Reserve 59 varicoceles 59 ThermoDox ® clinical 59 pulmonary metastasis 59 metastatic gastric 59 catheter angiography 59 ABSORB trial 59 Breast Cancers 59 allogeneic HSCT 59 underwent surgical resection 59 HIV seropositive 59 Clinical Practice Guideline 59 Clinical Evaluation 59 Breast Cancer Risk 59 Severe Sepsis 59 Clinical Outcome 59 multiple logistic regression 59 BRIM2 59 ASTEROID 59 Phase 2b Clinical Trial 59 MERIT ES 59 Patient Outcomes 59 Cancer Incidence 59 Myocardial Ischemia 59 LUX Lung 59 randomized controlled clinical 59 clinicopathological 59 muscle biopsies 59 J Clin Endocrinol Metab 59 pancreatic adenocarcinoma 59 circulating endothelial cells 59 nonsmall cell lung cancer 59 Prostate Specific Antigen PSA 59 NeuroImage 59 National Oncologic PET 59 gastric cardia 59 GBA mutations 59 Coronary CTA 59 Gamma Imaging BSGI 59 INCB# [003] 59 HER2 positive metastatic breast 59 Contrast Enhanced 59 arthrography 59 NATRECOR ® 59 Prostate Cancer Screening 59 kidney urologic 59 Cardiotoxicity 59 inconclusive Pap 59 CATIE AD 59 Acute Liver Failure 59 MassGeneral Institute 59 OPT CHF 59 undergone hysterectomies 59 improve impulse conduction 59 cranial radiation 59 Coronary Revascularization 59 Delcath Phase III 59 ERSPC 59 GnRH agonists 59 lipid lowering drugs 59 #rd Annual CTRC 59 Current Controlled Trials 59 BEZ# 59 PANVAC VF 59 Oncologic 59 CURRENT OASIS 7 59 ICSI cycles 59 Mammography Screening 59 endometrial carcinoma 59 Getzenberg 59 metastatic malignant 59 psoriatic arthritis PsA 59 MADIT II 59 ENGAGE AF TIMI 59 multivariate analyzes 59 journal Hepatology 59 sorafenib Nexavar 59 APEX PD 59 CP CPPS 59 Randomized Evaluation 59 multicenter multinational 59 postmenopausal hormone 59 Thoracic Oncology 59 Prostate AdenoCarcinoma Treatment 59 Normative Aging Study 59 Randomized controlled 59 Myocardial Infarction Study 59 colon resections 59 multicenter clinical 59 Study ARIC 59 BARACLUDE ® 58 core needle biopsy 58 renal tumors 58 USA UroToday.com 58 cardiac perfusion 58 Vertos II 58 postmenopausal hormone replacement 58 Inflammatory Markers 58 PFO migraine 58 cisplatin resistant 58 pelvic malignancies 58 diagnostic angiography 58 PD2i ® 58 ROCHESTER Minn. Mayo Clinic 58 histologic examination 58 Demonstrates Sustained 58 Nutrition Examination 58 premenopausal 58 carotid stenosis 58 Estradiol 58 Vaccine Protects Against 58 CT angiograms 58 Metastatic Melanoma 58 hormone therapy estrogen 58 PARTNER Trial 58 urine cytology 58 Solid Tumors 58 Percutaneous Coronary Intervention 58 ID NCT# 58 chronic prostatitis chronic 58 Thoracic Oncology Program 58 midstage clinical 58 Randomized Double Blind 58 Localized Prostate Cancer 58 PET CT scans 58 Common Terminology Criteria 58 clinicopathologic 58 Arteriosclerosis Thrombosis 58 AVADO 58 p# biomarker 58 Ductal carcinoma 58 Relapsing Multiple Sclerosis 58 CALERIE 58 Communities ARIC study 58 SPIRIT III 58 pathologic examination 58 Therapeutic Advances 58 Fondaparinux 58 Magnetic resonance 58 pCR 58 ADMIRE HF 58 Environ Health Perspect 58 Pediatric Diabetes 58 lobular carcinoma 58 Aflibercept 58 transcranial Doppler ultrasound 58 serum lipid levels 58 Hepatitis C Virus 58 Male Infertility 58 coronary CT angiography 58 C#BL/#J mice 58 Urologic Cancer 58 DBMD 58 Physical Therapy PTJ 58 NSABP C 58 Papillary 58 STICH trial 58 Surgeons Oncology 58 Duke Comprehensive Cancer 58 Placebo Controlled Trial 58 Aggressive Drug Evaluation 58 TGFBR1 * 6A 58 randomized controlled multicenter 58 Kidney Transplantation 58 tumor histology 58 carotid atherosclerosis 58 NeuroStar TMS Therapy 58 Alzheimer Disease Cooperative 58 Stent Thrombosis 58 Patency 58 Adult Stem Cell Therapy 58 landmark ATHENA 58 prostate ovarian 58 DMSc 58 infantile colic 58 histopathologic examination 58 genomewide 58 asymptomatic carotid stenosis 58 Adenoma 58 Vascugel ® 58 PCPT 58 Sipuleucel T 58 polyp recurrence 58 Advanced Renal Cell 58 singleton pregnancies 58 Sequenced Treatment Alternatives 58 Breast Density 58 Ann Intern Med 58 B Cell Lymphoma 58 pathologic correlation 58 benign nodules 58 cervical intraepithelial neoplasia 58 Endocrine Society #st 58 minimally symptomatic 58 Pancreas Cancer 58 Patients Treated With 58 BERKELEY CA UroToday.com 58 unresectable tumors 58 PON1 activity 58 UM Comprehensive Cancer 58 Study AREDS 58 stage IIIB 58 Watchful Waiting 58 SYNTAX trial 58 CHARISMA trial 58 AACR #st Annual Meeting 58 aripiprazole Abilify 58 Recurrent Prostate Cancer 58 Kaplan Meier analysis 58 metastatic neuroendocrine tumors 58 prospective observational studies 58 fluvastatin 58 helical CT 58 bladder ovarian 58 florbetaben 58 Kidney Disorders 58 Cell Lymphoma 58 double blinded randomized 58 Am J Cardiol 58 Uterine Fibroid 58 THE STUDY 58 Circulating Tumor Cells 58 quadrivalent HPV vaccine 58 Percutaneous Tibial Nerve Stimulation 58 Soft Tissue Sarcoma 58 ACCORD Lipid 58 endoscopists 58 narcolepsy cataplexy 58 Coronary Angiography 58 dietary questionnaires 58 cancer mCRC 58 Biopsies 58 CTRC AACR San Antonio 58 Third Eye Retroscope 58 Molecular Genetic 58 Hodgkin lymphoma HL 58 Bucuvalas Inc. 58 bone density measurements 58 HIVNET 58 SLNB 58 UroVysion 58 Refractory Angina 58 thyrotropin levels 58 CYPHER Stent 58 HER2 amplified 58 Serological 58 colon rectal 58 testosterone supplementation 58 preoperative chemotherapy 58 Tesmilifene 58 Chicago Multidisciplinary Symposium 58 Gastrointestinal Oncology 58 Xelox 58 preoperative MRI 58 undergoing coronary angiography 58 thorough QT 58 MIVI TRUST 58 ductal breast cancer 58 gadobutrol 58 abnormal Pap 58 Chronic Lymphocytic Leukemia CLL 58 prospectively enrolled 58 oral antidiabetic medication 58 ImmuKnow assay 58 neoadjuvant treatment 58 lymph node biopsies 58 DXA scan 58 fecal immunochemical test 58 Tumor Microenvironment 58 Hepatocellular Carcinoma 58 serum estradiol 58 Complications Trial 58 Judith Hochman 58 Antihypertensive 58 Benign Prostatic Hyperplasia 58 computed tomography CT scans 58 XIENCE V Stent System 58 tibolone 58 Study HERS 58 Cochrane Systematic Review 58 gadolinium enhanced 58 VaD 58 cervical lesions 58 colon polyp 58 gallstone disease 58 antiretroviral naïve 58 malignant lymphoma 58 Aortic Dissection 58 conventional coronary angiography 58 Hrushesky 58 liver transplant recipients 58 dacarbazine chemotherapy 58 CombAT 58 mutant mice lacking 58 perineural invasion 58 Recurrent Breast Cancer 58 transplantation HSCT 58 blinded randomized placebo controlled 58 Early Childhood Longitudinal Study 58 Survivorship Program 58 prostate cancer PCa 58 TRANSFORMS 58 CAVEATS 58 called elastography distinguished 58 Prostate Cancer Treatment 58 Risk Stratification 58 worsening thrombocytopenia 58 ASCO GI 58 deCODE AF TM 58 Skin sterol 58 carotid IMT 58 nonmelanoma skin cancer 58 epoetin alpha 58 fetal chromosomal 58 neuropathologic 58 gene BRCA2 58 invasive aspergillosis 58 Infarct 58 FluCAM arm 58 Osteoporotic Fractures 58 CTAP# Capsules 58 sunitinib Sutent 58 BRCA1 BRCA2 58 VerifyNow 58 multicentric 58 Nesiritide 58 Therapeutics TCT scientific 58 BMC Musculoskeletal Disorders 58 venlafaxine Effexor 58 Cervical Pathology 58 ductal adenocarcinoma 58 Digene HPV Test 58 perimenopausal women 58 postmenopausal women 58 pancreatic prostate 58 colorectal cancer incidence 58 ACTIVE W 58 multivariable analysis 58 Communities ARIC Study 58 Treat Parkinson Disease 58 VATS lobectomy 58 Li Fraumeni 58 Immunotherapeutic 58 hematopoietic cancers 57 lobular breast cancer 57 childhood acute lymphoblastic 57 #:#-# [029] 57 symptomatic carotid stenosis 57 Fine Needle Aspiration 57 metachronous 57 J Clin Oncol 57 HNRCA 57 Intravenous immunoglobulin 57 Lung Screening 57 Combination Treatment 57 subclinical hyperthyroidism 57 BRCA2 carriers 57 Breast Cancer Treatment 57 metastatic HER2 positive 57 Pivotal Trial 57 DHEA supplementation 57 colorectal bowel 57 BRCA mutation carriers 57 Psychosomatic Research 57 Roentgenology 57 Systemic Sclerosis 57 colonography 57 Complicated Skin 57 Aspergillus nidulans 57 GAMMAGARD 57 Hemodialysis Patients 57 Pavia Italy 57 glucocorticoid induced osteoporosis 57 Claudia Henschke 57 #-# Full Text 57 Randomized Phase III 57 Colorectal Screening 57 multicenter Phase III 57 homocysteine concentrations 57 Multicenter Phase 57 oral bisphosphonate 57 ovarian cervical 57 RECIST Response Evaluation Criteria 57 Leukemias 57 MRgFUS 57 Vizilite 57 BRAF mutated 57 randomized Phase III 57 Imaging Diagnostic 57 immunohistochemical staining 57 adrenocortical cancer 57 computerized tomography scans 57 Improves Outcomes 57 Cohort Study MACS 57 hormone receptor negative 57 CIN3 57 Oncotype DX colon cancer 57 perinatal outcomes 57 gastric adenocarcinoma 57 atypical Hemolytic Uremic Syndrome 57 bilateral oophorectomy 57 Neoadjuvant Chemotherapy 57 resectable pancreatic cancer 57 Afib 57 FDG PET 57 Vascular Disease 57 ARCALYST ® rilonacept 57 Study Evaluating 57 paclitaxel cisplatin 57 Educational Longitudinal Study 57 ZOLINZA 57 Bone Mineral Density 57 ConclusionThis 57 relapsing remitting MS RRMS 57 subclinical atherosclerosis 57 Dual Antiplatelet Therapy 57 simplex virus 57 journal Anesthesia 57 radical nephrectomy 57 facial clefts 57 Malignancies 57 radioimmunotherapy RIT 57 axillary lymph nodes 57 Phase IIIb clinical 57 Neurologic Disorders 57 Controlled Trial 57 mammographically 57 ANCHOR trial 57 multivariate Cox 57 Eculizumab 57 Multiple logistic regression 57 Optical Coherence Tomography 57 IL# PE#QQR 57 axillary lymph node dissection